Epidemiología de la hipertensión arterial en España. Situación actual y perspectivas
Tài liệu tham khảo
2002, Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT), JAMA, 288, 2981, 10.1001/jama.288.23.2981
Wolf-Maier, 2003, Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States, JAMA, 289, 2363, 10.1001/jama.289.18.2363
Banegas, 2002, El problema del control de la hipertensión en España, Hipertensión, 19, 377
Díez-Martínez, 2005, Una nueva etapa en la vida de hipertensión, Hipertensión, 22, 187, 10.1016/S0212-8241(05)71561-9
2003, Guidelines Committee, J Hypertens, 21, 1011, 10.1097/00004872-200306000-00001
MacMahon, 2005, Hypertension time to move on, Lancet, 365, 1108, 10.1016/S0140-6736(05)71148-X
Banegas, 2005, Hipertensión arterial. Objetivos terapéuticos, magnitud y manejo, Cardiovasc Risk Factors, 14, 150
Marín, 2005, Guía Española de Hipertensión Arterial 2005, Hipertensión, 22, 1
2000, Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy, Lancet, 355, 253, 10.1016/S0140-6736(99)12323-7
2001, Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6, 105 individuals with previous stroke or transient ischaemic attack, Lancet, 358, 1033, 10.1016/S0140-6736(01)06178-5
Kearney, 2005, Global burden of hypertension: analysis of worldwide data, Lancet, 365, 217, 10.1016/S0140-6736(05)70151-3
Banegas, 2002, El problema de la hipertensión arterial en España, Rev Clin Esp, 202, 12, 10.1016/S0014-2565(02)70972-7
Banegas, 1998, Blood pressure in Spain: distribution, awareness, control, and benefits of a reduction in average pressure, Hypertension, 32, 998, 10.1161/01.HYP.32.6.998
Banegas, 2002, Hypertension magnitude and management in the elderly population of Spain, J Hypertens, 20, 2157, 10.1097/00004872-200211000-00014
Chobanian, 2003, The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report, JAMA, 289, 2560, 10.1001/jama.289.19.2560
Banegas, 1999, Mortalidad relacionada con la presión arterial y la hipertensión en España, Med Clin (Barc), 112, 489
Hajjard, 2003, Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000, JAMA, 290, 199, 10.1001/jama.290.2.199
Primatesta, 2004, Hypertension management and control among English adults aged 65 years and older in 2000 and 2001, J Hypertens, 22, 1093, 10.1097/00004872-200406000-00008
Gutiérrez-Fisac, 2005, Prevalencia de obesidad en la población adulta española: 14 años de incremento continuado, Med Clin (Barc), 124, 196, 10.1157/13071485
Lloyd-Jones, 2005, Hypertension in adults across the age spectrum. Current outcomes and control in the community, JAMA, 294, 466, 10.1001/jama.294.4.466
Egan, 2003, Awareness, knowledge, and attitudes of older Americans about high blood pressure, Arch Intern Med, 163, 681, 10.1001/archinte.163.6.681
Wang, 2005, Epidemiology of uncontrolled hypertension in the United States, Circulation, 112, 1651, 10.1161/CIRCULATIONAHA.104.490599
Wolf-Maier, 2004, Hypertension treatment and control in five European countries, Canada, and the United States, Hypertension, 43, 10, 10.1161/01.HYP.0000103630.72812.10
Medrano, 2005, Factores de riesgo cardiovascular en la población española: metaanálisis de estudios transversales, Med Clin (Barc), 124, 606, 10.1157/13074389
1993
Puras, 1998, Prevalence, awareness, treatment, and control of hypertension in a Spanish population, Eur J Epidemiol, 14, 31, 10.1023/A:1007483916158
Compañ, 1998, Prevalencia y control de la hipertensión arterial en la población adulta de la Comunidad Valenciana, 1994, Med Clin (Barc), 110, 328
Masiá, 1998, High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence, J Epidemiol Community Health, 52, 707, 10.1136/jech.52.11.707
Sans, 2001, Tendencias de la prevalencia, conocimiento, tratamiento y control de la hipertensión arterial entre 1986 y 1996: estudio MONICA-Cataluña, Med Clin (Barc), 117, 246, 10.1016/S0025-7753(01)72077-5
Dalfó Baqué, 2001, Diagnóstico y seguimiento de la hipertensión arterial en Cataluña. Estudio DISEHTAC, Aten Primaria, 28, 305, 10.1016/S0212-6567(01)70380-0
Seculi, 2003, Detection of cardiovascular risk factors in the reformed primary care network in Catalonia. Comparison between the years 1995 and 2000, Aten Primaria, 31, 156
Benítez Camps, 2005, Comparison with 1996 data, Aten Primaria, 35, 7, 10.1157/13071038
Llisterri, 2004, Control de la presión arterial en la población hipertensa española atendida en Atención Primaria. Estudio PRESCAP 2002, Med Clin (Barc), 122, 165, 10.1157/13057821
Coca Payeras, 2005, Evolución del control de la hipertensión arterial en Atención Primaria en España. Resultados del estudio Controlpres 2003, Hipertensión, 22, 5, 10.1016/S0212-8241(05)74809-X
Redón, 2003, Control de la hipertensión arterial basada en la automedición ambulatoria de la presión arterial: Estudio APACHE, Med Clin (Barc), 120, 728, 10.1157/13048057
Banegas, 2004, Blood pressure control and physician management of hypertension in hospital hypertension units in Spain, Hypertension, 43, 1338, 10.1161/01.HYP.0000127424.59774.84
Banegas, 2005, Control of cardiovascular risk factors among hypertensives attended at hypertension units in Spain
1997, The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI), Arch Intern Med, 157, 2413, 10.1001/archinte.1997.00440420033005
1999, Guidelines Subcommittee, J Hypertens, 17, 151
Álvarez-Sala, 2005, Estudio Prevencat: control del riesgo cardiovascular en Atención Primaria, Med Clin (Barc), 124, 406, 10.1157/13072841
De la Peña, 2005, Control integral de los factores de riesgo en pacientes en alto y muy alto riesgo cardiovascular en España. Estudio CIFARC, Med Clin (Barc), 124, 44, 10.1157/13070450
Coca, 2002, Evolución del control de la hipertensión arterial en España. Resultados del estudio Controlpres 2001, Hipertensión, 19, 390
Márquez, 2002, El incumplimiento terapéutico en España. Análisis de los estudios publicados entre 1984 y 2001, Hipertensión, 19, 12
Kannel, 2003, Prevalence and implications of uncontrolled systolic hypertension, Drugs Aging, 20, 277, 10.2165/00002512-200320040-00004
Oliveira, 2002, Physician-related barriers to the effective management of uncontrolled hypertension, Arch Intern Med, 162, 413, 10.1001/archinte.162.4.413
García-Pavía P, Gonzáles-Mirelis J, Pastorín R, Bruna M, Raez J, Tabuenca AI, et al. Análisis de las áreas de mejora del control de la hipertensión arterial en la práctica clínica de la Atención Primaria. Rev Clin Esp. 2005 (en prensa)
Márquez, 2004, 1
Divisón, 2005, Aparatos de medida de la presión arterial en las consultas de Atención Primaria, Aten Primaria, 36, 248, 10.1157/13079146
Cooper, 1997, Evaluation of an electronic blood pressure device for epidemiological studies, Blood Press Monit, 2, 35
Rodríguez-Roca, 2005, Control de la hipertensión arterial en la población española ≥ 65 años asistida en Atención Primaria, Rev Esp Cardiol, 58, 359, 10.1157/13073892
Hermida, 2005, Treatment of non-dipper hypertension with bedtime administration of valsartan, J Hypertens, 23, 1913, 10.1097/01.hjh.0000182522.21569.c5
Redon, 2002, Uncontrolled early morning blood pressure in medicated patients: the ACAMPA study. Analysis of the control of blood pressure using ambulatory blood pressure monitoring, Blood Press Monit, 7, 111, 10.1097/00126097-200204000-00004
Fuster, 1999, Epidemic of cardiovascular disease and stroke: the three main challenges. Presented at the 71st scientific sessions of the American Heart Association. Dallas, Texas, Circulation, 99, 1132, 10.1161/01.CIR.99.9.1132
Pardell H, editor. Hipertensión Arterial en España. Liga Española para la lucha contra la hipertensión arterial. 2.ª ed. Madrid 1987.
Vara, 2004, Use of antihypertensive agents in Cantabria, Spain [1995-2002]: discrepancy with the published evidence, Gac Sanit, 18, 406, 10.1157/13067400
Martínez, 1999, Frequency and determinants of white coat hypertension in mild to moderate hypertension: a Primary Care-based study. Monitorizacion Ambulatoria de la Presion Arterial (MAPA)-Area 5 Working Group, Am J Hypertens, 12, 251, 10.1016/S0895-7061(98)00262-3
Saez, 2000, Orthostatic hypotension in the aged and its association with antihypertensive treatment, Med Clin (Barc), 114, 525
The State of Health Care Quality 2004. Washington, DC: National Committee for Quality Assurance; 2004.
Marín, 2005, Prevalencia de factores de riesgo cardiovascular en la infancia y adolescencia: estudio Carmona, Clin Invest Arterioscl, 17, 112
Krousel-Wood, 2004, Primary prevention of essential hypertension, Med Clin North Am, 88, 223, 10.1016/S0025-7125(03)00126-3
Appel, 1997, A clinical trial of the effects of dietary patterns on blood pressure: DASH Collaborative Research Group, N Engl J Med, 336, 117, 10.1056/NEJM199704173361601
